Display options
Cite
Lee DH, Min JH, Bae SB, et al. Idiopathic erythrocytosis in a patient on chronic hemodialysis. Kidney Res Clin Pract. 2014;34(1):60-3doi: 10.1016/j.krcp.2014.09.004.
Lee, D. H., Min, J. H., Bae, S. B., Gil, H. W., Yang, J. O., Lee, E. Y., & Hong, S. Y. (2015). Idiopathic erythrocytosis in a patient on chronic hemodialysis. Kidney research and clinical practice, 34(1), 60-3. https://doi.org/10.1016/j.krcp.2014.09.004
Lee, Dong Hyun, et al. "Idiopathic erythrocytosis in a patient on chronic hemodialysis." Kidney research and clinical practice vol. 34,1 (2015): 60-3. doi: https://doi.org/10.1016/j.krcp.2014.09.004
Lee DH, Min JH, Bae SB, Gil HW, Yang JO, Lee EY, Hong SY. Idiopathic erythrocytosis in a patient on chronic hemodialysis. Kidney Res Clin Pract. 2015 Mar;34(1):60-3. doi: 10.1016/j.krcp.2014.09.004. Epub 2014 Nov 27. PMID: 26484022; PMCID: PMC4570647.
Copy Download .nbib Format: NLM
Share it on

Kidney Res Clin Pract. 2015 Mar;34(1):60-3. doi: 10.1016/j.krcp.2014.09.004. Epub 2014 Nov 27.

Idiopathic erythrocytosis in a patient on chronic hemodialysis.

Kidney research and clinical practice

Dong Hyun Lee, Ji Hye Min, Sang Byung Bae, Hyo Wook Gil, Jong Oh Yang, Eun Young Lee, Sae Yong Hong

Affiliations

  1. Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Cheonan, Korea.

PMID: 26484022 PMCID: PMC4570647 DOI: 10.1016/j.krcp.2014.09.004

Abstract

A 78-year-old man on hemodialysis presented to our hospital with erythrocytosis. He had started hemodialysis 4 years previously, with a hemoglobin level of 9.8 g/dL, and was administered erythropoiesis stimulating agents and ferrous sulfate. Two years previously, his hemoglobin level increased to 14.5 g/dL and the treatment for anemia was discontinued. He continued hemodialysis thrice weekly; however, the hemoglobin level had increased to 17.0 g/dL at the time of presenting to our hospital. His serum erythropoietin level was 31.4 mIU/mL (range, 3.7-31.5 mIU/mL), carboxyhemoglobin level was 0.6% (range, 0-1.5%), and oxygen saturation in ambient air was 95.4%. The JAK2 V617F mutation was not observed and other bone marrow abnormalities were not identified. The patient was diagnosed with bladder cancer and a transurethral resection was performed. Eight months after the treatment of bladder cancer, his hemoglobin level was 15.1 g/dL, and he was diagnosed with idiopathic erythrocytosis.

Keywords: End-stage renal disease; Erythrocytosis; Hemodialysis

References

  1. Int J Urol. 1998 Sep;5(5):493-4; discussion 495 - PubMed
  2. Arch Intern Med. 1983 Sep;143(9):1822-3 - PubMed
  3. Nephrol Dial Transplant. 2007 Oct;22(10):2900-8 - PubMed
  4. Harefuah. 1989 Dec 1;117(11):358-60 - PubMed
  5. Am J Nephrol. 2013;37(4):333-8 - PubMed
  6. Clin J Am Soc Nephrol. 2007 May;2(3):604-10 - PubMed
  7. Int J Lab Hematol. 2008 Dec;30(6):447-59 - PubMed
  8. Am J Kidney Dis. 2003 Jul;42(1):E3-4 - PubMed
  9. Hemodial Int. 2010 Jul;14(3):333-6 - PubMed
  10. Hemodial Int. 2009 Oct;13 Suppl 1:S30-3 - PubMed
  11. Br J Haematol. 2014 May;165(4):519-28 - PubMed
  12. Nihon Hinyokika Gakkai Zasshi. 1983 Jun;74(6):1044-50 - PubMed

Publication Types